Wednesday, January 13, 2021

Combination treatment for methamphetamine use disorder shows promise in NIH study


News Release 13-Jan-2021
NIH/National Institute on Drug Abuse


A combination of two medications, injectable naltrexone and oral bupropion, was safe and effective in treating adults with moderate or severe methamphetamine use disorder in a double-blind, placebo-controlled Phase III clinical trial. The findings suggest this combination therapy may be a promising addition to current approaches to treatment, such as cognitive behavioral therapy and contingency management interventions, for a very serious condition that remains difficult to treat and overcome.


tags: drug abuse, drug use,

No comments:

Post a Comment